IUPAC/Chemical Name
Acetic acid, 2-chloro-2-(3-chloro-4-cyclohexylphenyl)-
InChi Key
GXEUNRBWEAIPCN-UHFFFAOYSA-N
InChi Code
InChI=1S/C14H16Cl2O2/c15-12-8-10(13(16)14(17)18)6-7-11(12)9-4-2-1-3-5-9/h6-9,13H,1-5H2,(H,17,18)
SMILES Code
O=C(O)C(Cl)C1=CC=C(C2CCCCC2)C(Cl)=C1
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
287.18
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Talesnik J, Hsia JC. Coronary flow reactions to arachidonic acid are inhibited by docosahexaenoic acid. Eur J Pharmacol. 1982 May 21;80(2-3):255-8. PubMed PMID: 6213418.
2: Mathur PP, Smyth RD. Physiological disposition and subcellular localization of 14C-fenclorac in the rat. Res Commun Chem Pathol Pharmacol. 1979 Jul;25(1):23-31. PubMed PMID: 451357.
3: DeLong AF, Polk A, Martin G, Smyth RD, Reavey-Cantwell NH. GLC assay of fenclorac in human plasma. J Pharm Sci. 1978 Aug;67(8):1171-3. PubMed PMID: 307596.
4: Mathur PP, Riley RL, Richardson CP, Reavey-Cantwell NH. The inhibition of prostaglandin synthetase in vivo by nonsteroidal anti-inflammatory agents. Agents Actions. 1977 Jul;7(2):283-8. PubMed PMID: 409117.
5: Lee JK, Smyth RD, Polk A, Herczeg T, Tsuei CT, Reavey-Cantwell NH. Quantitative determination of fenclorac in serum. J Pharm Sci. 1977 Jun;66(6):832-4. PubMed PMID: 301563.
6: Procaccini RL, Smyth RD, Reavey-Cantwell NH. Studies on the in vitro inhibition of prostaglandin synthetase by fenclorac (alpha, m-dichloro-p-cyclohexylphenylacetic acid) and indomethacin. Biochem Pharmacol. 1977 Jun 1;26(11):1051-7. PubMed PMID: 18151.
7: DeLong AF, Smyth RD, Polk A, Nayak RK, Martin G, Douglas GH, Reavey-Cantiwell NH. Comparative metabolism of fenclorac in rat, dog, monkey, and man. Drug Metab Dispos. 1977 Mar-Apr;5(2):122-31. PubMed PMID: 15804.
8: Won CM, Zalipsky JJ, Patel DM, Reavey-Cantwell NH. Kinetics of hydrolysis of fenclorac. J Pharm Sci. 1977 Jan;66(1):73-7. PubMed PMID: 13197.
9: Smyth RD, Mathur PP, Procaccini RL, Carr GS, Reavey-Cantwell NH. Comparative effects of fenclorac and indomethacin on gastrointestinal blood loss in the rat. Toxicol Appl Pharmacol. 1976 Dec;38(3):507-15. PubMed PMID: 1087763.
10: Nuss GW, Smyth RD, Breder CH, Hitchings MJ, Mir GN, Reavey-Cantwell NH. The antiphlogistic, antinociceptive and antipyretic properties of fenclorac. Agents Actions. 1976 Nov;6(6):735-47. PubMed PMID: 1008019.
11: Visalli AJ, Patel DM, Reavey-Cantwell NH. GLC assay for fenclorac. J Pharm Sci. 1976 Nov;65(11):1686-8. PubMed PMID: 994003.
12: Yellin TO, Buck SH, Sperow JW. Inhibition of the diarrheal and cardiac actions of arachidonic acid by fenclorac, a new anti-inflammatory agent. Life Sci. 1976 Oct 15;19(8):1211-6. PubMed PMID: 994722.
